13th International Conference on Environmental Mutagens

Maintaining Genomic Health in a Changing World

53rd Annual Meeting of the EMGS

August 27 - September 1, 2022 - Ottawa Canada

 

ICEM-Logo-Final-Animation.gif


ICEM 2022 Sponsors

Become a Sponsor  

Diamond Level: 
Morningside Foundation
NIEHS R13 Grant
TwinStrand Biosciences


Platinum Level:
Escher Fund for Autism 

Health and Environmental Sciences Institute
Proctor & Gamble, Co. 
Health Canada 
US-FDA R13
University of Ottawa 
Carleton University
 


Gold Level:
Bristol Myers Squibb
Canadian Institutes for Health Research


Silver Level:
Burroughs Wellcome Fund

Elsevier
United Kingdom Environmental Mutagen Society
Gilead Sciences
National Cancer Institute (NCI)


Bronze Level:
Lhasa Limited

RIFM
Moltox, Molecular Toxicology, Inc. 
BASF
Toxys
Litron Laboratories
Instem
MultiCASE


Supporter
Mutagen-Brasil

Johnson & Johnson
University of Michigan


Contributors
European Environmental Mutagenesis and Genomics Society

Japanese Environmental Mutagen and Genome Society
Journal of Biochemistry
Illumina
Pfizer Inc.
Environmental and Molecular Mutagenesis Journal 
Bill Kaufmann
Genetic Toxicology Association
Society of Toxicology


SIG MEETINGS 

SUNDAY, AUGUST 28

DNA Repair SIG Meeting: 7AM to 8AM | Governor General I - Level 4
Chair: Aishwarya Prakash, PhD, University of South Alabama, Mobile, AL, USA
Co-Chair: Amy Michelle Whitaker, Fox Chase Cancer Center, Philadelphia, PA, USA

SNI Co-Chari: Ryan Barnes, University of Pittsburgh, Pittsburgh, PA, USA 

Germ Cell and Heritable Effects SIG Meeting: 7AM to 8AM | Governor General II - Level 4
Chair:  Jonatan Axelsson, MD, PhD, Lund University and Skåne University Hospital, Malmö, Sweden

Co-Chairs: Habib A. Shojaei Saadi DVM, PhD, Health Canada, Ottawa, ON, Canada, Mathia L Colwell, University of Minnesota, St. Paul, MN, USA

MONDAY, AUGUST 29

Genomics and Data Sciences SIG Meeting: 7AM to 8AM | Governor General I - Level 4

Co-Chairs: Matthew Meier, Health Canada, Ottawa, ON, Canada, Christopher Faulk, PhD, University of Minnesota, St. Paul, MN, USA, Tess C Leuthner, Duke University, Durham, NC, USA

Applied Genetic Toxicology SIG Meeting: 7AM to 8AM | Governor General II - Level 4
Chair: Daniel J Roberts, MS, Charles River Laboratories, Skokie, IL, USA
Co-Chair: Alexandra S. Long, PhD, Health Canada, Ottawa, ON, USA

SNI Co-Chair: Eunnara Cho, Health Canada, Ottawa, ON, USA

TUESDAY, AUGUST 30

Genotoxicity Risk Assessment and Public Health SIG Meeting: 7AM to 8AM | Governor General I - Level 4
Chair: Catherine Gibbons, PhD, US EPA, Washington D.C., USA

Co-Chairs: Marc Andrew Beal, PhD, MSc & Julie Cox, Health Canada, Ottawa, ON, Canada, 

In Vivo Mutagenesis SIG Meeting: 7AM to 8AM | Governor General II - Level 4
Chair: Mark Fielden, PhD, Kate Therapeutics, San Diego, CA, USA

Co-Chairs: Charles C Valentine, III, M.Sc., TwinStrand Biosciences, Seattle, WA, USA, Shaofei Zhang, Pfizer, Groton, CT, USA

WEDNESDAY, AUGUST 31

Epigenomics SIG Meeting: 7AM to 8AM | Governor General I - Level 4
Chair: Isabelle R. Miousse, PhD, University of Arkansas for Medical Sciences, Little Rock, AR, USA
Co-Chair: Brian N Chorley, PhD, US EPA, Raleigh, NC, USA
SNI Co-Chair: Nicole Wanner, DVM, University of Minnesota Twin Cities, St. Paul, MN, USA